Idioma:

Letter by Chin et al Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”

Chin, Paul K L ; Wright, Daniel F B ; Florkowski, Christopher M

Circulation (New York, N.Y.), 2014-11, Vol.130 (22), p.e194-e194 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Letter by Chin et al Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”
Autor: Chin, Paul K L ; Wright, Daniel F B ; Florkowski, Christopher M
Assuntos: Atrial Fibrillation - drug therapy ; Atrial Fibrillation - physiopathology ; Benzimidazoles - adverse effects ; Benzimidazoles - therapeutic use ; beta-Alanine - analogs & derivatives ; Female ; Humans ; Kidney - physiology ; Male ; Warfarin - adverse effects ; Warfarin - therapeutic use
É parte de: Circulation (New York, N.Y.), 2014-11, Vol.130 (22), p.e194-e194
Notas: SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
Editor: United States: by the American College of Cardiology Foundation and the American Heart Association, Inc
Idioma: Inglês

Links

Voltar para lista de resultados